Share >  
Share
Share on Tumblr

Pharmaceutical Formulation Intermediates

News »

   latest by relevance
Syncom Formula Mar '12 sales at Rs 27.71 crore
May 19, 2012 at 17:36 | Source: Moneycontrol.com
Syncom Formulations has reported a sales turnover of Rs 27.71 crore and a net loss of Rs 1.10 crore for the quarter ended Mar '12
Biocon beats estimates, Q4 net down 3% YoY at Rs 98 cr
Apr 27, 2012 at 11:18 | Source: Moneycontrol.com
Pharmaceutical company Biocon has reported better than expected topline as well as bottomline numbers in its fourth quarter of FY12. Its net profit fell 3% to Rs 98 crore in the January-March quarter of 2012 from Rs 101 crore in a year ago period.
Strides Arcolab buys Sterile Formulations; stock up 2.4%
Apr 27, 2012 at 09:29 | Source: Moneycontrol.com
Strides Arcolab has bought Sterile Formulations unit for Rs 125 crore, reports CNBC-TV18.
Lupin to set up new formulations manufacturing plant
Apr 24, 2012 at 15:56 | Source: Moneycontrol.com
Drug maker Lupin is setting up a new formulations manufacturing facility at the special economic zone, Mihan in Nagpur.
Earnings growth may continue in pharma stocks: ICRA
Mar 14, 2012 at 16:27 | Source: Moneycontrol.com
ICRA has come out with its report on Indian pharmaceutical sector. According to the research firm, earnings growth will continue, benefitting from healthy growth in the domestic formulations business and steady growth expected in the U.S/Europe generics space on back of patent expiries.
Budget Expectations: Here's what analysts see in store for pharma sector
Mar 07, 2012 at 13:39 | Source: Moneycontrol.com
The Budget announcement by Finance Minister Pranab Mukherjee on March 16 is expected to be a mixed bag for pharmaceutical companies.

Videos »
Biocon beats estimates, Q4 net down 3% YoY at Rs 98 cr
Creapharm buy funded via internal accruals: Dishman Pharma
To see robust revenue from 2013: Nectar Lifesciences
Biocon aims to maintain 35-40% growth in branded healthcare
Short Cipla, says Prakash Diwan
more »

Photos »

  /  
Related News »
Crazy not to invest in Granules, Infinity Comp: Patherya
by which time the impact of the expansion the trebling capacity in finished dosages and more than doubling capacity in pharmaceutical formulation intermediates will be evident, so this is an amazing story,” he explained. On the other hand ...
May 21, 2012 at 06:43 | Source: MoneyControl.com
Research and Markets: Comparisons of Pharmaceutical Manufacturing between China and India - The Two Most Dynamic Emerging Countries
In contrast, India has been playing increasingly important roles in the global pharmaceutical manufacturing industry but in different areas. Its recognized capabilities in formulation development ... of advanced pharma intermediates and APIs.
May 21, 2012 at 10:39 | Source: Business Wire
New Zoning to Highlight High-Growth Sectors at China Pharma Events
as well as the formulation of competitive strategies for the future. The combined China pharma events provide visitors with a unique opportunity to network directly with key decision makers in the Asian pharmaceutical industry through both existing and new contacts.
May 23, 2012 at 20:45 | Source: wallstreet-online.de
TPI Reports Third Quarter Fiscal Year 2012 Financial Results
CHENGDU, China, May 15, 2012 /PRNewswire via COMTEX/ -- Tianyin Pharmaceutical Inc. (ASE ... manufacturing and sale of API and chemical intermediates of macrolide antibiotics. In January 2012, following a series of the internal quality ...
May 15, 2012 at 12:33 | Source: Marketwatch
Cambrex To Present At Jefferies 2012 Global Healthcare Conference
We offer Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery ... controlled substances and formulation of finished dosage form products.  For more information, please visit www.cambrex.com.
May 15, 2012 at 11:58 | Source: Yahoo Finance

Follow moneycontrol.com

Facebook Twitter Google Plus RSS Wap SMS SMS Alert iPad iPhone Blackberry OVI Android Window